Kv3.4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Kv3.4 Protein is a protein involved in neuronal signaling and function.
Gene: KCNC4 (to be created)
UniProt: Q9UQE8
Molecular Weight: ~73 kDa
Subcellular Localization: Neuronal membrane, particularly in hippocampus and cortex
Protein Family: Voltage-gated potassium channel, Kv3 subfamily
Kv3.4 channels are voltage-gated potassium channels with six transmembrane domains (S1-S6). Unlike Kv3.3, Kv3.4 channels exhibit slower activation and faster inactivation kinetics, making them particularly important for regulating repetitive firing patterns. The channel forms tetramers in the membrane and can form heteromeric complexes with other Kv3 subunits. Kv3.4 is heavily phosphorylated at multiple serine and threonine residues, modulating its gating properties.
Kv3.4 channels are expressed in hippocampal pyramidal neurons, cortical interneurons, and various subcortical nuclei. They play important roles in regulating neuronal excitability, particularly during repetitive firing. These channels contribute to the afterhyperpolarization following action potentials and help maintain firing frequency during sustained depolarization. Kv3.4 is important for auditory processing, particularly in the inferior colliculus and cochlear nuclei.
Altered Kv3.4 expression has been reported in AD brain, particularly in regions vulnerable to neurodegeneration. The channel may play a role in hippocampal hyperexcitability observed in early AD. Aβ can enhance Kv3.4 currents, potentially disrupting the balance of excitation and inhibition.
While KCNC4 mutations are less common than KCNC3 in SCA, they have been associated with cerebellar ataxia phenotypes. Dysfunction leads to Purkinje cell firing abnormalities and cerebellar circuit dysfunction.
Kv3.4 channel dysfunction may contribute to epileptogenesis by altering neuronal firing patterns. The channel's role in GABAergic interneurons is particularly important for maintaining inhibitory tone.
Kv3.4 modulators are being investigated for treating cerebellar disorders and epilepsy. Several pharmacological compounds can enhance or inhibit Kv3.4 currents. The channel's accessibility on the neuronal surface makes it a potential target for antibody-based therapies.
The study of Kv3.4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Kv3.4 channels exhibit unique gating characteristics:
Activation
Inactivation
Deactivation
Phosphorylation
Modulation
| Compound | Effect | Status |
|---|---|---|
| DPP | Activator | Research |
| FCE | Blocker | Research |
| NS5806 | Modulator | Research |